BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

834 related articles for article (PubMed ID: 27943468)

  • 1. Progression of subcortical atrophy in mild Parkinson's disease and its impact on cognition.
    Foo H; Mak E; Yong TT; Wen MC; Chander RJ; Au WL; Sitoh YY; Tan LC; Kandiah N
    Eur J Neurol; 2017 Feb; 24(2):341-348. PubMed ID: 27943468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease: ICICLE-PD study.
    Mak E; Su L; Williams GB; Firbank MJ; Lawson RA; Yarnall AJ; Duncan GW; Owen AM; Khoo TK; Brooks DJ; Rowe JB; Barker RA; Burn DJ; O'Brien JT
    Brain; 2015 Oct; 138(Pt 10):2974-86. PubMed ID: 26173861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploratory analysis of neuropsychological and neuroanatomical correlates of progressive mild cognitive impairment in Parkinson's disease.
    Lee JE; Cho KH; Song SK; Kim HJ; Lee HS; Sohn YH; Lee PH
    J Neurol Neurosurg Psychiatry; 2014 Jan; 85(1):7-16. PubMed ID: 23828835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcortical shape analysis of progressive mild cognitive impairment in Parkinson's disease.
    Chung SJ; Shin JH; Cho KH; Lee Y; Sohn YH; Seong JK; Lee PH
    Mov Disord; 2017 Oct; 32(10):1447-1456. PubMed ID: 28737237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive deficits in mild Parkinson's disease are associated with distinct areas of grey matter atrophy.
    Mak E; Zhou J; Tan LC; Au WL; Sitoh YY; Kandiah N
    J Neurol Neurosurg Psychiatry; 2014 May; 85(5):576-80. PubMed ID: 24133286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of hippocampal subfields in the progression of cognitive decline related to Parkinson's disease.
    Foo H; Mak E; Chander RJ; Ng A; Au WL; Sitoh YY; Tan LC; Kandiah N
    Neuroimage Clin; 2017; 14():37-42. PubMed ID: 28116240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of small vessel disease correlates with cortical thinning in Parkinson's disease.
    Foo H; Mak E; Yong TT; Wen MC; Chander RJ; Au WL; Tan L; Kandiah N
    Parkinsonism Relat Disord; 2016 Oct; 31():34-40. PubMed ID: 27397577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortical thinning associated with mild cognitive impairment in Parkinson's disease.
    Segura B; Baggio HC; Marti MJ; Valldeoriola F; Compta Y; Garcia-Diaz AI; Vendrell P; Bargallo N; Tolosa E; Junque C
    Mov Disord; 2014 Oct; 29(12):1495-503. PubMed ID: 25100674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinson's disease with mild cognitive impairment: severe cortical thinning antedates dementia.
    Gasca-Salas C; García-Lorenzo D; Garcia-Garcia D; Clavero P; Obeso JA; Lehericy S; Rodríguez-Oroz MC
    Brain Imaging Behav; 2019 Feb; 13(1):180-188. PubMed ID: 28710667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
    Gao Y; Nie K; Huang B; Mei M; Guo M; Xie S; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
    Neurosci Lett; 2017 Sep; 658():121-132. PubMed ID: 28823894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Grey matter atrophy in cognitively impaired Parkinson's disease.
    Melzer TR; Watts R; MacAskill MR; Pitcher TL; Livingston L; Keenan RJ; Dalrymple-Alford JC; Anderson TJ
    J Neurol Neurosurg Psychiatry; 2012 Feb; 83(2):188-94. PubMed ID: 21890574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal brain atrophy distribution in advanced Parkinson's disease: What makes the difference in "cognitive status" converters?
    Gorges M; Kunz MS; Müller HP; Liepelt-Scarfone I; Storch A; Dodel R; Hilker-Roggendorf R; ; Berg D; Kalbe E; Braak H; Del Tredici K; Baudrexel S; Huppertz HJ; Kassubek J
    Hum Brain Mapp; 2020 Apr; 41(6):1416-1434. PubMed ID: 31789477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mild cognitive impairment is linked with faster rate of cortical thinning in patients with Parkinson's disease longitudinally.
    Hanganu A; Bedetti C; Degroot C; Mejia-Constain B; Lafontaine AL; Soland V; Chouinard S; Bruneau MA; Mellah S; Belleville S; Monchi O
    Brain; 2014 Apr; 137(Pt 4):1120-9. PubMed ID: 24613932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cortical thickness in de novo patients with Parkinson disease and mild cognitive impairment with consideration of clinical phenotype and motor laterality.
    Danti S; Toschi N; Diciotti S; Tessa C; Poletti M; Del Dotto P; Lucetti C
    Eur J Neurol; 2015 Dec; 22(12):1564-72. PubMed ID: 26212370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease.
    Sunwoo MK; Jeon S; Ham JH; Hong JY; Lee JE; Lee JM; Sohn YH; Lee PH
    Eur J Neurol; 2014 Jun; 21(6):922-e50. PubMed ID: 24661277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
    Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
    Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral white matter hyperintensity in Parkinson's disease: a major risk factor for mild cognitive impairment.
    Kandiah N; Mak E; Ng A; Huang S; Au WL; Sitoh YY; Tan LC
    Parkinsonism Relat Disord; 2013 Jul; 19(7):680-3. PubMed ID: 23623194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mild cognitive impairment in patients with Parkinson's disease is associated with increased cortical degeneration.
    Hanganu A; Bedetti C; Jubault T; Gagnon JF; Mejia-Constain B; Degroot C; Lafontaine AL; Chouinard S; Monchi O
    Mov Disord; 2013 Sep; 28(10):1360-9. PubMed ID: 23801590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal assessment of the pattern of cognitive decline in non-demented patients with advanced Parkinson's disease.
    Gasca-Salas C; Estanga A; Clavero P; Aguilar-Palacio I; González-Redondo R; Obeso JA; Rodríguez-Oroz MC
    J Parkinsons Dis; 2014; 4(4):677-86. PubMed ID: 25208730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mild cognitive impairment reverters have a favorable cognitive prognosis and cortical integrity in Parkinson's disease.
    Chung SJ; Park YH; Yoo HS; Lee YH; Ye BS; Sohn YH; Lee JM; Lee PH
    Neurobiol Aging; 2019 Jun; 78():168-177. PubMed ID: 30947112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.